000			01464 a2200469 4500
005			20250516224659.0
264		0	_c20140904
008			201409s 0 0 rus d
022			_a0869-2092
040			_aNLM _beng _cNLM
100	1		_aIvashchenko, A V
245	0	0	_a[Preclinical study of AV0012 early stage inhibitor of hepatitis C virus infection: I. In vitro ADME and pharmacokinetics]. _h[electronic resource]
260			_bEksperimental'naia i klinicheskaia farmakologiia _c2014
300			_a33-41 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article
650	0	4	_aAnimals
650	0	4	_aAntiviral Agents _xchemistry
650	0	4	_aCattle
650	0	4	_aCell Line
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aFlavivirus _xmetabolism
650	0	4	_aFlavivirus Infections _xdrug therapy
650	0	4	_aHaplorhini
650	0	4	_aHepacivirus _xmetabolism
650	0	4	_aHepatitis C _xdrug therapy
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aRats
700	1		_aIamanushkin, P M
700	1		_aMit'kin, O D
700	1		_aEzhova, E V
700	1		_aKorzinov, O M
700	1		_aShevkun, N A
700	1		_aKoriakova, A G
700	1		_aKarapetian, R N
700	1		_aBychko, V V
700	1		_aIvashchenko, A A
700	1		_aAgrba, V Z
700	1		_aLapin, B A
700	1		_aOrlov, S V
773	0		_tEksperimental'naia i klinicheskaia farmakologiia _gvol. 77 _gno. 4 _gp. 33-41
999			_c24055812 _d24055812